Answers are grounded in this paper and cite their sources.
Cancer is associated with metabolic disorders, yet the impact of endocrine, nutritional and metabolic diseases (ENMs) on cancer remains unclear. Here, we show the associations of 25 ENMs with cancer trajectories, from primary cancer incidence to multi-primary cancers and mortality, using a multi-state model in a prospective cohort of 405,023 participants. Our findings reveal heterogeneous associations of ENMs across cancer sites and types, identifying 8 cancer-related ENMs that define four subtypes: C1 (iron deficiency/metabolism disorders dominated), C2 (type 2 diabetes dominated), C3 (lipid/lipoprotein metabolism disorders dominated), and C4 (osteoporosis dominated). Subtype-specific and subtype-shared proteomic mediators are identified and their contributions are quantified, with RNASET2 emerging as the major shared mediator. Furthermore, a deep-learning model integrating ENM subtypes and mediators enables personalized prediction of cancer incidence (AUCs = 0.80-0.90) and performs better than conventional Cox models. Our findings highlight the relevance of ENMs to cancer risk, providing mechanistic insights into metabolism-associated tumorigenesis.
No takes yet. Share an insight, caveat, or question.
Jie et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: